Short- and long-term effects of erythropoietin treatment on endothelial progenitor cell levels in patients with cardiorenal syndrome

OBJECTIVE: Patients with cardiorenal syndrome (CRS) have high cardiovascular morbidity. Endothelial progenitor cells (EPC) constitute an endogenous vascular repairsystem, protecting against atherosclerosis development. Erythropoietin (EPO) treatment may have beneficial effects by mobilizing EPC from...

Descripción completa

Detalles Bibliográficos
Autores principales: Jie, Kim E, van der Putten, Karien, Bergevoet, Marloes W T, Doevendans, Pieter A, Gaillard, Carlo A J M, Braam, Branko, Verhaar, Marianne C
Formato: Texto
Lenguaje:English
Publicado: BMJ Group 2010
Materias:
Cardiorenal Syndrome
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002834/
https://www.ncbi.nlm.nih.gov/pubmed/21071558
http://dx.doi.org/10.1136/hrt.2010.194654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002834/
https://www.ncbi.nlm.nih.gov/pubmed/21071558
http://dx.doi.org/10.1136/hrt.2010.194654

Ejemplares similares